Table 1 Baseline characteristics of the study population (N = 487)
From: Selected nasogastric lavage in patients with nonvariceal upper gastrointestinal bleeding
Age, median (range), years | 69 (18–94) |
Male | 260 (53.4) |
Comorbidities | 374 (76.8) |
Diabetes mellitus | 120 (24.6) |
Cerebrovascular accident | 57 (11.7) |
Coronary artery disease | 50 (10.3) |
Chronic kidney disease | 27 (5.5) |
Liver cirrhosis | 56 (11.5) |
Previous peptic ulcer disease | 63 (12.9) |
Antithrombotic/anticoagulant use | 144 (29.6) |
Aspirin | 101 (20.7) |
Clopidogrel | 36 (7.4) |
Dual antiplatelet therapy | 20 (4.1) |
Warfarin | 9 (1.8) |
DOAC | 20 (4.1) |
NSAIDs use | 43 (8.8) |
Steroid use | 10 (2.1) |